Prostate Cancer

Osteoporosis Medication Improves Bone Health in ADT-Treated Prostate Cancer

Osteoporosis Medication Improves Bone Health in ADT-Treated Prostate Cancer

By

Osteoporosis medications were found to reduce bone mineral density loss and risk of fracture in men with nonmetastatic prostate cancer being treated with androgen-deprivation therapy.

Cabazitaxel in Prostate Cancer: Reduced Dose Noninferior to Standard Dose

Cabazitaxel in Prostate Cancer: Reduced Dose Noninferior to Standard Dose

By

A smaller dose of cabazitaxel (C20) is noninferior to a larger dose (C25) in the post-docetaxel treatment of mCRPC.

Cabazitaxel Does Not Prolong Overall Survival vs Docetaxel in Metastatic Prostate Cancer

Cabazitaxel Does Not Prolong Overall Survival vs Docetaxel in Metastatic Prostate Cancer

By

Cabazitaxel does not prolong OS in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer compared with the first-line chemotherapy agent docetaxel.

Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms

Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms

By

Meta-analysis of data from more than 50 studies reaffirms that vasectomy is not associated with increased risk of prostate cancer.

Obese Men at Higher Risk for Aggressive Prostate Cancer

Obese Men at Higher Risk for Aggressive Prostate Cancer

Study found taller and heavier males were more likely to develop prostate cancer, and they are also more likely to die of the disease.

Long Term Survivors of Prostate Cancer Express Treatment Decision Regret for Up to 15 Years

Long Term Survivors of Prostate Cancer Express Treatment Decision Regret for Up to 15 Years

By

Study results show that patients with prostate cancer express treatment decision regret, with concerns regarding sexual function, bowel function, and PSA most commonly associated with regret.

Metabolism of Next-Generation Prostate Cancer Drugs Share Similarities

Metabolism of Next-Generation Prostate Cancer Drugs Share Similarities

By

How the body metabolizes next-generation anti-androgen agents affects their anti-tumor activity in the treatment of prostate cancer.

Prostate-specific PET and CT Imaging Improves Detection of Disease and Patient Care

Prostate-specific PET and CT Imaging Improves Detection of Disease and Patient Care

By

Prostate-specific molecular imaging, such as PET and CT, can detect more cancer and improve patient care.

Significance of Prostate Cancer Treatment-Related Factors Differ in Black, White Men

Significance of Prostate Cancer Treatment-Related Factors Differ in Black, White Men

By

A survey of men with prostate cancer revealed that treatment-related factors impact treatment decisions differently in black men compared with white men.

Prehabilitation May Benefit Older Men Initiating ADT for Prostate Cancer

Prehabilitation May Benefit Older Men Initiating ADT for Prostate Cancer

By

Prehabilitation before initiating ADT in older men with prostate cancer may improve functioning, even in men on short-term ADT.

Better Understanding of Prostate Cancer Genetic Test Results Needed

Better Understanding of Prostate Cancer Genetic Test Results Needed

By

Some men who undergo multigene testing for inherited prostate cancer misinterpret findings of variants of uncertain significance.

Survival Increased With First-Line Abiraterone-ADT Combination for Hormone-Naïve Prostate Cancer

Survival Increased With First-Line Abiraterone-ADT Combination for Hormone-Naïve Prostate Cancer

By

Addition of abiraterone to androgen deprivation therapy for patients with hormone-naïve advanced prostate cancer may be a new standard of care.

Continued Enzalutamide Strategy Fails to Benefit mCRPC

Continued Enzalutamide Strategy Fails to Benefit mCRPC

By

Men who had PSA progression on enzalutamide but continued on the drug did not have improved PFS when abiraterone was added to their therapy.

Testosterone and Prostate Cancer Treatment

Testosterone and Prostate Cancer Treatment

Testosterone may offer an inexpensive alternative to other prostate cancer therapies, new research indicates.

Drinking Coffee Might Reduce Risk of Developing Prostate Cancer

Drinking Coffee Might Reduce Risk of Developing Prostate Cancer

By

Men who drank 3 or more cups of Italian style coffee per day had a lower risk of developing prostate cancer.

Mitochondrial Bioenergetics Profile Indicates Likelihood of Radiation-Induced Fatigue in Prostate Cancer

Mitochondrial Bioenergetics Profile Indicates Likelihood of Radiation-Induced Fatigue in Prostate Cancer

By

Mitochondrial oxidative phosphorylation rate in lymphocytes of patients with nonmetastatic prostate cancer appears to be associated with fatigue.

Multimodal Strategy Shows Promise in Metastatic Prostate Cancer

Multimodal Strategy Shows Promise in Metastatic Prostate Cancer

By

New paradigm of hormone therapy, surgery, and radiation therapy was shown effective at achieving undetectable disease in patients with metastatic prostate cancer.

Eischens Yoga May Benefit Men Undergoing Radiation Therapy for Prostate Cancer

Eischens Yoga May Benefit Men Undergoing Radiation Therapy for Prostate Cancer

By

Patients who practiced Eischens yoga twice a week had less fatigue, sexual dysfunction, and certain scores related to quality of life.

New Criteria for Appropriate Use of Bone Scintigraphy to Diagnose and Manage Prostate and Breast Cancer

New Criteria for Appropriate Use of Bone Scintigraphy to Diagnose and Manage Prostate and Breast Cancer

By

Several clinical societies came together to create appropriate use criteria for the use of bone scintigraphy in patients with prostate and breast cancer.

PSA Screening Rates Level Off in United States

PSA Screening Rates Level Off in United States

Decline in prostate-specific antigen (PSA) screening followed U.S. Preventive Services Task Force recommendations.

Family History Does Not Exclude Active Surveillance as Treatment Option for Prostate Cancer

Family History Does Not Exclude Active Surveillance as Treatment Option for Prostate Cancer

By

Family history does not predict aggressiveness of prostate cancer or suitability for active surveillance as a treatment option.

Hormone Refractory Prostate Cancer Responds to Abiraterone Acetate in Some Cases

Hormone Refractory Prostate Cancer Responds to Abiraterone Acetate in Some Cases

By

Abiraterone acetate and prednisone reduced PSA levels in a small group of clinical trial participants with metastatic prostate cancer who did not initially respond to ADT.

Yoga Can Help Ease Side Effects of Prostate Cancer Treatment

Yoga Can Help Ease Side Effects of Prostate Cancer Treatment

patients with prostate cancer who attended yoga classes had less fatigue and better sexual and urinary function.

E4 Steroid Reduces Testosterone Levels, Treats Advanced Prostate Cancer

E4 Steroid Reduces Testosterone Levels, Treats Advanced Prostate Cancer

By

Steroid produced by human fetal liver reduces testosterone levels, holding potential as treatment for advanced prostate cancer.

Disparities Growing in Prescreening Discussions About Prostate-Specific Antigen Testing

Disparities Growing in Prescreening Discussions About Prostate-Specific Antigen Testing

By

Conversations about benefits and drawbacks of PSA testing improved after the USPSTF updated its recommendations on PSA testing; however, some disparities in quality of these discussions increased.

Prostate Cancer Response to Immunotherapy Improved With Combination Therapy

Prostate Cancer Response to Immunotherapy Improved With Combination Therapy

By

Immunotherapy alone is not effective in prostate cancer; however, combining it with PD-1/PD-L1 and VISTA inhibitors is effective.

ASCO, Cancer Care Ontario Update Recommendations on Brachytherapy in Prostate Cancer

ASCO, Cancer Care Ontario Update Recommendations on Brachytherapy in Prostate Cancer

By

ASCO and Cancer Care Ontario issued a joint update to guidelines for brachytherapy for prostate cancer that take into account new evidence.

VERT Program Eases Patient Anxiety, Improves Understanding of Treatment for Prostate Cancer

VERT Program Eases Patient Anxiety, Improves Understanding of Treatment for Prostate Cancer

By

Virtual Environment Radiotherapy (VERT) program eases anxiety and improves understanding of radiation therapy for patients with prostate cancer.

Little Difference in QoL Between Various Treatments, Active Surveillance in Prostate Cancer

Little Difference in QoL Between Various Treatments, Active Surveillance in Prostate Cancer

By

QoL after radical prostatectomy, EBRT, or brachytherapy vs active surveillance for prostate cancer are similar.

Interactive App Helps Manage Prostate Cancer Treatment Symptoms

Interactive App Helps Manage Prostate Cancer Treatment Symptoms

By

Interactive app helps patients with prostate cancer manage their treatment-related symptoms.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs